TERBINAFINE Side Effects

7023568-8 | Eye Swelling, Hypokinesia, Joint Swelling, Urticaria
on Sep 17, 2010 Female patient from UNITED KINGDOM , 23 years of age, was treated with Terbinafine (View Usage). Patient experienced the following unwanted or unexpected effects: eye swelling, hypokinesia, joint swelling, urticaria. Terbinafine dosage: .

7020677-4 | Arthritis Reactive, Eye Swelling, Hypokinesia, Joint Swelling, Urticaria
Patient was taking Terbinafine (View Usage). Patient had the following side effects: arthritis reactive, eye swelling, hypokinesia, joint swelling, urticaria on Sep 17, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 23 years of age, . Terbinafine dosage: 250 Mg.

7018884-X | Anal Haemorrhage, Colitis Ulcerative
Adverse event was reported on Sep 14, 2010 by a Female patient taking Terbinafine (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 56 years of age, After Terbinafine was administered, patient had the following side effects: anal haemorrhage, colitis ulcerative.

7009522-0 | Anal Haemorrhage, Colitis Ulcerative
on Sep 14, 2010 Female patient from UNITED KINGDOM , 56 years of age, weighting 192.9 lb, was treated with Terbinafine (View Usage). Patient experienced the following unwanted or unexpected effects: anal haemorrhage, colitis ulcerative. Terbinafine dosage: 250 Mg, Unk.


7007733-1 | Metrorrhagia
on Sep 14, 2010 Female patient from UNITED KINGDOM , 36 years of age, was diagnosed with onychomycosis, contraception and was treated with Terbinafine (View Usage). Patient had the following side effects: metrorrhagia. Terbinafine dosage: . During the same period patient was treated with MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ).

6987434-6 | Metrorrhagia
Patient was taking Terbinafine (View Usage). After Terbinafine was administered, patient had the following side effects: metrorrhagia on Sep 06, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 36 years of age, was diagnosed with onychomycosis, contraception and. Terbinafine dosage: 250 Mg, Qd. During the same period patient was treated with DEPO PROVERA (150 Mg, Q3mo) (View Depo-provera Review and Depo-provera Label ).

6672893-9 | Blood Creatinine Increased, Circulatory Collapse, Lethargy, Protein Urine Present, Renal Impairment, Tubulointerstitial Nephritis
Adverse event was reported on Mar 29, 2010 by a Male patient taking Terbinafine (View Usage) (Dosage: 250 Mg Daily) was diagnosed with tinea pedis and. Location: AUSTRALIA , 33 years of age, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, circulatory collapse, lethargy, protein urine present, renal impairment, tubulointerstitial nephritis.

6671095-X | Finger Amputation, Nail Dystrophy, Nail Operation, Neoplasm Malignant, Soft Tissue Injury
on Mar 18, 2010 Female patient from UNITED STATES , 73 years of age, was diagnosed with tinea capitis and was treated with Terbinafine (View Usage). Patient had the following side effects: finger amputation, nail dystrophy, nail operation, neoplasm malignant, soft tissue injury. Terbinafine dosage: Unk.

6651927-1 | Disturbance In Attention, Dizziness, Dysgeusia, Impaired Driving Ability, Nausea
on Mar 08, 2010 Female patient from , 28 years of age, was diagnosed with tinea pedis and was treated with Terbinafine (View Usage). After Terbinafine was administered, patient had the following side effects: disturbance in attention, dizziness (What is dizziness?), dysgeusia, impaired driving ability, nausea (What is nausea?). Terbinafine dosage: 250mg, Oral. During the same period patient was treated with NORDETTE 28 (View Nordette-28 Review and Nordette-28 Label ).

6621852-0 | Glomerular Filtration Rate Decreased, Renal Impairment
Patient was taking Terbinafine (View Usage). Patient experienced the following unwanted or unexpected effects: glomerular filtration rate decreased, renal impairment on Feb 17, 2010 from Additional patient health information: Male patient , 63 years of age, weighting 151.5 lb, was diagnosed with onychomycosis and. Terbinafine dosage: 250mg, Unk, Oral. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), BECLOMETASONE NASAL (View Beclometasone Nasal Review and Beclometasone Nasal Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), DOXAZOSIN (View Doxazosin Review and Doxazosin Label ), EXENATIDE (View Exenatide Review and Exenatide Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), REMIPRIL (View Remipril Review and Remipril Label ).

6556899-6 | Glomerular Filtration Rate Decreased, Renal Impairment
Adverse event was reported on Jan 14, 2010 by a Male patient taking Terbinafine (View Usage) (Dosage: ) was diagnosed with onychomycosis, type 2 diabetes mellitus and. Location: UNITED KINGDOM , 63 years of age, weighting 151.5 lb, Patient had the following side effects: glomerular filtration rate decreased, renal impairment. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), BECLOMETASONE (View Beclometasone Review and Beclometasone Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), DOXAZOSIN MESILATE (View Doxazosin Mesilate Review and Doxazosin Mesilate Label ), EXENATIDE (View Exenatide Review and Exenatide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

6552860-6 | Asthenia, Dizziness, Nausea, Paraesthesia
on Jan 07, 2010 Male patient from , 43 years of age, weighting 149.9 lb, was diagnosed with onychomycosis and was treated with Terbinafine (View Usage). After Terbinafine was administered, patient had the following side effects: asthenia, dizziness (What is dizziness?), nausea (What is nausea?), paraesthesia. Terbinafine dosage: 250mg - Daily - Oral.

6550749-X | Glomerular Filtration Rate Decreased, Renal Impairment
on Jan 14, 2010 Male patient from UNITED KINGDOM , 63 years of age, was diagnosed with onychomycosis, type 2 diabetes mellitus and was treated with Terbinafine (View Usage). Patient experienced the following unwanted or unexpected effects: glomerular filtration rate decreased, renal impairment. Terbinafine dosage: 250 Mg, Unk. During the same period patient was treated with AMLODIPINE (10 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN CALCIUM (10 Mg, Qd) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), BECLOMETHASONE DIPROPIONATE (Unk) (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), BENDROFLUMETHIAZIDE (2.5 Mg, Qd) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), DOXAZOSIN MESYLATE (4 Mg, Qd) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), EXENATIDE (60 Ug, Unk) (View Exenatide Review and Exenatide Label ), METFORMIN (500 Mg, Bid) (View Metformin Review and Metformin Label ), RAMIPRIL (5 Mg, Bid) (View Ramipril Review and Ramipril Label ).

6547407-4 | Asthenia, Dizziness, Nausea, Paraesthesia
Patient was taking Terbinafine (View Usage). Patient had the following side effects: asthenia, dizziness (What is dizziness?), nausea (What is nausea?), paraesthesia on Jan 14, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 43 years of age, weighting 149.9 lb, was diagnosed with onychomycosis and. Terbinafine dosage: 250 Mg, Qd.

6547240-3 | Glomerular Filtration Rate Decreased, Renal Impairment
Adverse event was reported on Jan 14, 2010 by a Male patient taking Terbinafine (View Usage) (Dosage: ) was diagnosed with onychomycosis and. Location: UNITED KINGDOM , 63 years of age, weighting 151.5 lb, After Terbinafine was administered, patient had the following side effects: glomerular filtration rate decreased, renal impairment.

6544019-3 | Pneumonia, Rash, Toxic Epidermal Necrolysis
on Jan 14, 2010 Male patient from UNITED KINGDOM , 76 years of age, weighting 154.3 lb, was diagnosed with fungal infection (What is fungal infection?) and was treated with Terbinafine (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), rash (What is rash?), toxic epidermal necrolysis. Terbinafine dosage: .

6530297-3 | Erythema Multiforme, Stevens-johnson Syndrome, Toxic Epidermal Necrolysis
on Dec 17, 2009 Female patient from UNITED STATES , 47 years of age, was diagnosed with onychomycosis and was treated with Terbinafine (View Usage). Patient had the following side effects: erythema multiforme, stevens-johnson syndrome, toxic epidermal necrolysis. Terbinafine dosage: 250 Mg, Daily. Patient was hospitalized.

6529488-7 | Asthenia, Dizziness, Nausea, Paraesthesia
Patient was taking Terbinafine (View Usage). After Terbinafine was administered, patient had the following side effects: asthenia, dizziness (What is dizziness?), nausea (What is nausea?), paraesthesia on Dec 22, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 43 years of age, weighting 149.9 lb, was diagnosed with onychomycosis and. Terbinafine dosage: 250 Mg, Qd.

6526072-6 | Asthenia, Dizziness, Nausea, Paraesthesia
Adverse event was reported on Dec 21, 2009 by a Male patient taking Terbinafine (View Usage) (Dosage: ) was diagnosed with onychomycosis and. Location: UNITED KINGDOM , 43 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: asthenia, dizziness (What is dizziness?), nausea (What is nausea?), paraesthesia.

6524577-5 | Asthenia, Dizziness, Nausea, Paraesthesia
on Dec 21, 2009 Male patient from UNITED KINGDOM , 43 years of age, weighting 149.9 lb, was diagnosed with onychomycosis and was treated with Terbinafine (View Usage). Patient had the following side effects: asthenia, dizziness (What is dizziness?), nausea (What is nausea?), paraesthesia. Terbinafine dosage: 250 Mg, Qd.

6491638-9 | Disturbance In Attention, Road Traffic Accident, Unevaluable Event
on Nov 25, 2009 Male patient from UNITED KINGDOM , 45 years of age, was diagnosed with fungal skin infection and was treated with Terbinafine (View Usage). After Terbinafine was administered, patient had the following side effects: disturbance in attention, road traffic accident, unevaluable event. Terbinafine dosage: 250 Mg (250 Mg, 1 In 1 D), Oral. During the same period patient was treated with MOVELAT (MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER, SALICYLIC ACID) (View Movelat (mucopolysaccharide Polysulfuric Acid Ester, Salicylic Acid) Review and Movelat (mucopolysaccharide Polysulfuric Acid Ester, Salicylic Acid) Label ), BETAMETHASONE VALERATE (View Betamethasone Valerate Review and Betamethasone Valerate Label ), DAKTACORT (HYDROCORTISONE, MICONAZOLE NITRATE) (View Daktacort (hydrocortisone, Miconazole Nitrate) Review and Daktacort (hydrocortisone, Miconazole Nitrate) Label ), TERBINAFINE HCL (View Terbinafine Hcl Review and Terbinafine Hcl Label ).

6417006-3 | Malaise, Pain
Patient was taking Terbinafine (View Usage). Patient experienced the following unwanted or unexpected effects: malaise, pain (What is pain?) on Oct 08, 2009 from Additional patient health information: Male patient , 67 years of age, was diagnosed with onychomycosis and. Terbinafine dosage: 250mg, Daily, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), EZETIMBE 10MG (View Ezetimbe 10mg Review and Ezetimbe 10mg Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6381224-3 | Abnormal Sensation In Eye, Arrhythmia, Blood Pressure Fluctuation, Cardiovascular Disorder, Dizziness, Tachycardia, Visual Impairment
Adverse event was reported on Sep 15, 2009 by a Female patient taking Terbinafine (View Usage) (Dosage: 250 Mg) was diagnosed with onychomycosis and. Location: GERMANY , child 12 years of age, Patient had the following side effects: abnormal sensation in eye, arrhythmia (What is arrhythmia?), blood pressure fluctuation, cardiovascular disorder, dizziness (What is dizziness?), tachycardia, visual impairment. Patient was hospitalized.

6274667-X | Arthralgia, Myalgia, Nausea, Paraesthesia, Rash, Urticaria
on Jul 04, 2009 Male patient from , 29 years of age, was diagnosed with onychomycosis and was treated with Terbinafine (View Usage). After Terbinafine was administered, patient had the following side effects: arthralgia, myalgia, nausea (What is nausea?), paraesthesia, rash (What is rash?), urticaria. Terbinafine dosage: 250mg - Oral.

5538348-X | Mallory-weiss Syndrome
on Oct 29, 2007 Male patient from UNITED KINGDOM , 44 years of age, was treated with Terbinafine (View Usage). Patient experienced the following unwanted or unexpected effects: mallory-weiss syndrome. Terbinafine dosage: Oral. During the same period patient was treated with AMLODIPINE (AMLODIPINE, 10MG) (View Amlodipine (amlodipine, 10mg) Review and Amlodipine (amlodipine, 10mg) Label ), CARBIMAZOLE (CARBIMAZOLE, 5 MG) (View Carbimazole (carbimazole, 5 Mg) Review and Carbimazole (carbimazole, 5 Mg) Label ), DOXAZOSIN (DOXAZOSIN, 4 MG) (View Doxazosin (doxazosin, 4 Mg) Review and Doxazosin (doxazosin, 4 Mg) Label ). Patient was hospitalized.

5383737-X | Disturbance In Attention, Psychomotor Retardation
Patient was taking Terbinafine (View Usage). Patient had the following side effects: disturbance in attention, psychomotor retardation on Jul 09, 2007 from GERMANY Additional patient health information: Female patient , 24 years of age, . Terbinafine dosage: .

5379926-0 | Disturbance In Attention, Psychomotor Retardation
Adverse event was reported on Jun 29, 2007 by a Female patient taking Terbinafine (View Usage) (Dosage: ) . Location: GERMANY , 24 years of age, After Terbinafine was administered, patient had the following side effects: disturbance in attention, psychomotor retardation.

5379735-2 | Depression, Night Sweats, Restlessness
on Jun 29, 2007 Female patient from GERMANY , 54 years of age, was treated with Terbinafine (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), night sweats, restlessness. Terbinafine dosage: .

5370005-5 | Agitation, Depression, Night Sweats
on Jun 19, 2007 Female patient from GERMANY , 54 years of age, was treated with Terbinafine (View Usage). Patient had the following side effects: agitation, depression (What is depression?), night sweats. Terbinafine dosage: .

5370003-1 | Disturbance In Attention, Psychomotor Retardation
Patient was taking Terbinafine (View Usage). After Terbinafine was administered, patient had the following side effects: disturbance in attention, psychomotor retardation on Jun 19, 2007 from GERMANY Additional patient health information: Female patient , 24 years of age, . Terbinafine dosage: .

5363268-3 | Blood Albumin Decreased, Blood Immunoglobulin A Increased, Blood Immunoglobulin G Increased, Chronic Hepatitis, Contusion, Hepatic Cirrhosis, Hepatic Necrosis, Hepatitis B, Hepatomegaly
Adverse event was reported on Jun 18, 2007 by a Male patient taking Terbinafine (View Usage) (Dosage: ) . Location: UNITED STATES , 57 years of age, Patient experienced the following unwanted or unexpected effects: blood albumin decreased, blood immunoglobulin a increased, blood immunoglobulin g increased, chronic hepatitis, contusion, hepatic cirrhosis, hepatic necrosis, hepatitis b (What is hepatitis b?), hepatomegaly.

5299145-6 | Haematospermia
on Apr 04, 2007 Male patient from UNITED KINGDOM , 60 years of age, weighting 187.4 lb, was treated with Terbinafine (View Usage). Patient had the following side effects: haematospermia. Terbinafine dosage: 250 Mg, Qd.

5262871-9 | Asthenia, Blood Creatine Phosphokinase Increased, Chromaturia, Myalgia, Rhabdomyolysis
on Feb 27, 2007 Male patient from SPAIN , 24 years of age, was diagnosed with tinea capitis and was treated with Terbinafine (View Usage). After Terbinafine was administered, patient had the following side effects: asthenia, blood creatine phosphokinase increased, chromaturia, myalgia, rhabdomyolysis. Terbinafine dosage: 250 Mg, Qd (15 Days/mth).

5224751-4 | Blood Immunoglobulin E Increased, Condition Aggravated, Fungal Skin Infection, Malaise, Pyrexia, Skin Hyperpigmentation
Patient was taking Terbinafine (View Usage). Patient experienced the following unwanted or unexpected effects: blood immunoglobulin e increased, condition aggravated, fungal skin infection, malaise, pyrexia, skin hyperpigmentation on Dec 14, 2006 from BELGIUM Additional patient health information: Male patient , 45 years of age, was diagnosed with fungal skin infection and. Terbinafine dosage: 250 Mg/d.

5208751-6 | Asthenia, Depression, Limb Discomfort, Mental Impairment, Mood Altered, Oral Discomfort, Suicidal Ideation
Adverse event was reported on Jan 08, 2007 by a Female patient taking Terbinafine (View Usage) (Dosage: 250 Mg/day) was diagnosed with nail tinea and. Location: GERMANY , 59 years of age, Patient had the following side effects: asthenia, depression (What is depression?), limb discomfort, mental impairment, mood altered, oral discomfort, suicidal ideation. During the same period patient was treated with PRESOMEN (View Presomen Review and Presomen Label ).

5208741-3 | Blood Creatinine Increased, Leukocytosis, Lymphocytic Infiltration, Neutrophilia, Pyrexia, Rash Papular, Rash Pustular, Skin Lesion
on Jan 08, 2007 Female patient from UNITED KINGDOM , 62 years of age, was diagnosed with nail infection and was treated with Terbinafine (View Usage). After Terbinafine was administered, patient had the following side effects: blood creatinine increased, leukocytosis, lymphocytic infiltration, neutrophilia, pyrexia, rash papular, rash pustular, skin lesion. Terbinafine dosage: 250 Mg, Qd. Patient was hospitalized.

5196705-8 | Anxiety, Asthenia, Depression, Feeling Abnormal, Limb Discomfort, Mental Impairment, Mood Altered, Oral Discomfort, Suicidal Ideation
on Dec 22, 2006 Female patient from GERMANY , 59 years of age, was diagnosed with nail tinea and was treated with Terbinafine (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), asthenia, depression (What is depression?), feeling abnormal, limb discomfort, mental impairment, mood altered, oral discomfort, suicidal ideation. Terbinafine dosage: 250 Mg/day. During the same period patient was treated with PRESOMEN (View Presomen Review and Presomen Label ).

5191129-1 | Depression, Feeling Abnormal, Limb Discomfort, Mental Impairment, Mood Altered, Suicidal Ideation
Patient was taking Terbinafine (View Usage). Patient had the following side effects: depression (What is depression?), feeling abnormal, limb discomfort, mental impairment, mood altered, suicidal ideation on Dec 15, 2006 from GERMANY Additional patient health information: Female patient , 59 years of age, was diagnosed with nail tinea and. Terbinafine dosage: 250 Mg/day.

5130384-0 | Arthralgia, Liver Function Test Abnormal, Malaise, Purpura
Adverse event was reported on Oct 05, 2006 by a Female patient taking Terbinafine (View Usage) (Dosage: 250 Mg, Qd) was diagnosed with fungal infection (What is fungal infection?) and. Location: UNITED KINGDOM , 74 years of age, After Terbinafine was administered, patient had the following side effects: arthralgia, liver function test abnormal, malaise, purpura. During the same period patient was treated with ATENOLOL (50 Mg, Qd) (View Atenolol Review and Atenolol Label ), CEPHALEXIN (500 Mg, Qd) (View Cephalexin Review and Cephalexin Label ), ACETAMINOPHEN W/ CODEINE (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ), DIPROBASE (View Diprobase Review and Diprobase Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), ISPAGHULA HUSK (View Ispaghula Husk Review and Ispaghula Husk Label ), LEVOTHYROXINE SODIUM (100 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

5122874-1 | Dysgeusia, Dyspnoea, Panic Reaction
on Sep 25, 2006 Female patient from UNITED KINGDOM , 55 years of age, weighting 176.4 lb, was diagnosed with fungal infection (What is fungal infection?), pain (What is pain?) and was treated with Terbinafine (View Usage). Patient experienced the following unwanted or unexpected effects: dysgeusia, dyspnoea, panic reaction. Terbinafine dosage: 250mg / Day. During the same period patient was treated with ACETAMINOPHEN W/ CODEINE (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ).

5097499-7 | Dysgeusia, Eating Disorder
on Aug 16, 2006 Female patient from UNITED KINGDOM , weighting 136.7 lb, was diagnosed with onychomycosis and was treated with Terbinafine (View Usage). Patient had the following side effects: dysgeusia, eating disorder (What is eating disorder?). Terbinafine dosage: Qd, Oral. During the same period patient was treated with CO AMOXICLAV (CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE) (View Co-amoxiclav (clavulanic Acid, Amoxicillin Trihydrate) Review and Co-amoxiclav (clavulanic Acid, Amoxicillin Trihydrate) Label ), TIOCONAZOL (View Tioconazol Review and Tioconazol Label ).

5093816-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Diplopia, Dizziness, Fall, Hypoaesthesia Facial
Patient was taking Terbinafine (View Usage). After Terbinafine was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, diplopia, dizziness (What is dizziness?), fall (What is fall?), hypoaesthesia facial on Aug 23, 2006 from UNITED STATES Additional patient health information: Male patient , 50 years of age, was diagnosed with onychomycosis, bipolar disorder (What is bipolar disorder?), hypertension, gastrooesophageal reflux disease, erectile dysfunction (What is erectile dysfunction?) and. Terbinafine dosage: 250 Mg/day. During the same period patient was treated with BUPROPION HCL (300 Mg/day) (View Bupropion Hcl Review and Bupropion Hcl Label ), QUETIAPINE (300 Mg/day) (View Quetiapine Review and Quetiapine Label ), HYDROCHLOROTHIAZIDE (25 Mg/day) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), OMEPRAZOLE (20 Mg/day) (View Omeprazole Review and Omeprazole Label ), SILDENAFIL CITRATE (50 Mg/day) (View Sildenafil Citrate Review and Sildenafil Citrate Label ), CARBAMAZEPINE (900 Mg/day) (View Carbamazepine Review and Carbamazepine Label ). Patient was hospitalized.

5087316-3 | Syncope
Adverse event was reported on Aug 22, 2006 by a Male patient taking Terbinafine (View Usage) (Dosage: ) was diagnosed with nail tinea and. Location: UNITED KINGDOM , weighting 142.9 lb, Patient experienced the following unwanted or unexpected effects: syncope.

5087311-4 | Depressed Mood, Dissociation, Hyperhidrosis, Tearfulness
on Aug 11, 2006 Male patient from UNITED KINGDOM , 62 years of age, weighting 202.8 lb, was diagnosed with onychomycosis and was treated with Terbinafine (View Usage). Patient had the following side effects: depressed mood, dissociation, hyperhidrosis, tearfulness. Terbinafine dosage: 250mg Daily.

5082022-3 | Epidermal Necrosis, Erythema Multiforme, Leukopenia, Rash Erythematous, Skin Atrophy
on Aug 07, 2006 Female patient from UNITED STATES , 29 years of age, was diagnosed with systemic mycosis and was treated with Terbinafine (View Usage). After Terbinafine was administered, patient had the following side effects: epidermal necrosis, erythema multiforme, leukopenia, rash erythematous, skin atrophy. Terbinafine dosage: 250 Mg/day. Patient was hospitalized.

5020944-X | Abdominal Pain, Abdominal Pain Upper, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Neutrophil Percentage Increased, Pseudocyst, Shoulder Pain, White Blood Cell Count Increased
Patient was taking Terbinafine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil percentage increased, pseudocyst, shoulder pain, white blood cell count increased on Jun 07, 2006 from UNITED STATES Additional patient health information: Male patient , 53 years of age, weighting 145.0 lb, was diagnosed with rash (What is rash?) and. Terbinafine dosage: 250mg Qday Po. Patient was hospitalized.

4865917-2 | Erectile Dysfunction
Adverse event was reported on Dec 19, 2005 by a Male patient taking Terbinafine (View Usage) (Dosage: 250 Mg, Qd) was diagnosed with onychogryphosis and. Location: UNITED KINGDOM , 45 years of age, Patient had the following side effects: erectile dysfunction (What is erectile dysfunction?).

4865916-0 | Lymphadenopathy, Lymphopenia
on Dec 19, 2005 Female patient from UNITED KINGDOM , 40 years of age, was diagnosed with onychomycosis and was treated with Terbinafine (View Usage). After Terbinafine was administered, patient had the following side effects: lymphadenopathy, lymphopenia. Terbinafine dosage: 250 Mg, Qd.

4865915-9 | Self-injurious Ideation
on Dec 19, 2005 Male patient from UNITED KINGDOM , 16 years of age, was diagnosed with onychomycosis and was treated with Terbinafine (View Usage). Patient experienced the following unwanted or unexpected effects: self-injurious ideation. Terbinafine dosage: 250mg Daily.

4860789-4 | Antinuclear Antibody Positive, Arthralgia, Double Stranded Dna Antibody, Fatigue, Histone Antibody Positive, Malaise, Myalgia, Photosensitivity Reaction, Rash
Patient was taking Terbinafine (View Usage). Patient had the following side effects: antinuclear antibody positive, arthralgia, double stranded dna antibody, fatigue, histone antibody positive, malaise, myalgia, photosensitivity reaction, rash (What is rash?) on Nov 05, 2003 from CZECH REPUBLIC Additional patient health information: Female patient , 39 years of age, was diagnosed with nail tinea, arthritis (What is arthritis?) and. Terbinafine dosage: 250 Mg/d. During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ). Patient was hospitalized.